How type III collagen helps build and protect cartilage

Roles of Type III Collagen in the Matrix Assembly and Mechanobiology of Cartilage

NIH-funded research Drexel University · NIH-11325326

Researchers are looking at whether a protein called type III collagen helps cartilage form correctly and resist damage, which could matter for people with or at risk for osteoarthritis.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionDrexel University NIH-funded
Lab location1 site (Philadelphia, United States)
Project IDNIH-11325326 on NIH RePORTER

What this research studies

This project focuses on type III collagen and how it controls the tiny collagen fibers that give cartilage its strength and mechanical behavior. The team will use lab-grown cartilage and animal models, including a joint-injury model that mimics post‑traumatic osteoarthritis, to compare normal and collagen III–deficient tissue. They will measure fiber assembly, the pericellular matrix around cartilage cells, and how cells sense mechanical forces using microscopy and mechanical testing. Understanding these steps during growth, maintenance, and after injury could guide better materials or treatments that restore healthy cartilage structure.

Who could benefit from this research

Good fit: People with osteoarthritis, especially those with prior joint injuries that raise the risk of post‑traumatic OA, or patients willing to donate joint tissue for research would be most relevant to this work.

Not a fit: Patients without cartilage damage or whose symptoms are driven primarily by non‑cartilage causes (for example, purely inflammatory conditions) may not see direct benefit from this basic research in the near term.

Why it matters

Potential benefit: If successful, the findings could guide new regenerative materials or therapies that better restore cartilage structure and help slow or prevent osteoarthritis.

How similar studies have performed: Prior studies show collagen architecture affects cartilage mechanics, but targeting type III collagen specifically in cartilage formation and injury is a relatively new angle with translational benefit not yet proven.

Where this research is happening

Philadelphia, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.